Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal
Novartis acquisition of Cadent Therapeutics : Swiss pharma giant Novartis has agreed to acquire a US neuroscience company Cadent Therapeutics, in a deal worth up to $770 million. The consideration includes an upfront payment of $210 million and up to $560 million in milestone payments. Cadent Therapeutics was launched about three years ago via the […]
Novartis acquisition of Vedere Bio : US-based stealth-stage company Vedere Bio has been acquired by Swiss pharma giant Novartis in a deal worth up to $280 million, for its preclinical intravitreally-injected AAV gene therapy programs. The company is engaged in advancing photoreceptor-protein-based optogenetic therapies that are intravitreally delivered to the retina for restoring functional vision. […]
Continue reading …
Novartis acquisition of IFM Tre : Novartis has signed a deal worth up to $1.575 billion to acquire US biopharma company IFM Tre from IFM Therapeutics. Novartis acquisition of IFM Tre The acquisition of the US biopharma company, which was only launched last year, is expected to add certain immunomodulatory drugs to the Swiss pharma […]
Continue reading …
Blackstone Life Sciences, a private investment platform, has joined forces with Swiss drug maker Novartis to launch a new biopharma company called Anthos Therapeutics, which will focus on developing drugs for high-risk cardiovascular patients. Anthos Therapeutics, which will be headquartered in Cambridge, Massachusetts, is backed by a capital of $250 million from Blackstone Life Sciences. […]
Continue reading …
Business News Today
- Scanpoint Geomatics wins contract from BiharShariff Smart City
- Arbuthnot Banking sells Tay mortgage portfolio to OneSavings Bank
- Clothing retailer Gap to open $140m Customer Experience Center in Longview
- Kiwi insurer Tower to acquire legacy portfolio of ANZ
- World Insurance Associates acquires Corporate Risk Services in Arkansas
- Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
- Kotak Mahindra Bank acquires stake in new fintech company Ferbine
- Infosys to expand Pennsylvania Retirement Services Center of Excellence
- Energean takes full ownership of Israeli subsidiary
- Merck to acquire US biotech company Pandion Therapeutics for $1.8bn